Key result
Oleic acid reduced the rate of de novo lipogenesis by approximately half in Huh-7 hepatocytes, but had no significant effect in 3T3-L1 adipocytes.
Why the study?
Lipogenesis is a vital but often dysregulated metabolic pathway.
Absolute Event Rate: 0.005% vs 0.01%
p-value: p=<0.05
Oleic acid differentially regulates de novo lipogenesis depending on the cell type, inhibiting it in hepatocytes but not adipocytes, which may help explain its complex role in metabolism and liver disease.
Should not change practice; hypothesis-generating for cell-specific oleic acid effects on lipogenesis.
Lipogenesis is a vital but often dysregulated metabolic pathway. We report super-resolution multiplexed vibrational imaging of lipogenesis rates and pathways using isotopically labelled oleic acid and glucose as probes in live adipocytes and hepatocytes. These findings suggest oleic acid inhibits de novo lipogenesis (DNL), but not total lipogenesis, in hepatocytes. No significant effect is seen in adipocytes. These differential effects may be due to alternate regulation of DNL between cell types and could help explain the complicated role oleic acid plays in metabolism.
No takes yet. Share an insight, caveat, or question.
Castillo et al. (2023) studied this question. Oleic acid vs. BSA vehicle was evaluated on Rate of de novo lipogenesis (13C/12C lipid ratio per hour) (p=<0.05). Oleic acid reduced the rate of de novo lipogenesis by approximately half in Huh-7 hepatocytes, but had no significant effect in 3T3-L1 adipocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: